Market Overview

Johnson & Johnson Teams With Google On Surgery Robot Development

Johnson & Johnson Teams With Google On Surgery Robot Development
Related JNJ
Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares
Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4
The NOT Top 10 Stocks For The Next Decade (Seeking Alpha)

Johnson & Johnson (NYSE: JNJ) will develop robotic surgical devices through a collaboration with Google Inc (NASDAQ: GOOGL), the company said Friday.

Financial terms weren't disclosed.

Johnson & Johnson's Ethicon medical device unit will work with Google on robotic-assisted surgery, a type of minimally invasive surgery that uses technology to give surgeons improved control, access and accuracy during surgical procedures.

The deal is expected to close in the second quarter, subject to anti-trust review by the U.S. Department of Justice.

Shares of Google and Johnson & Johnson were unchanged on the news.

Robotic surgery equipment maker Intuitive Surgical, Inc. (NASDAQ: ISRG) was also unmoved.

A recent meta-analysis of more than 4,000 studies on robotic surgery offered insufficient evidence to determine whether robotic surgery is better than traditional minimally invasive surgery, Chris Schabowsk of ECRI Institute told HealthLine News.

Image credit: Public Domain

Posted-In: HealthLine NewsNews FDA Events Tech Best of Benzinga


Related Articles (ISRG + GOOGL)

View Comments and Join the Discussion!